文献速递慢性静脉疾病

单侧与双侧及分期与同期双侧主干静脉腔内消融的比较:血管质量倡议数据

Comparison of unilateral vs bilateral and staged bilateral vs concurrent bilateral truncal endovenous ablation in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-05-26

基于血管质量倡议2015-2019年数据,纳入5029例慢性静脉功能不全行主干静脉腔内消融患者,比较单侧与双侧及分期与同期双侧手术的结局。同期双侧与分期双侧在并发症和VCSS改善上无差异,同期双侧可安全实施而不增加发病率。

要点

  • 同期双侧主干静脉腔内消融不增加并发症风险。
  • 单侧与双侧手术在VCSS改善上无显著差异。
  • 同期与分期双侧手术的VCSS改善可能性无差异。

核心结论

  • 同期双侧主干静脉腔内消融可安全进行,与分期双侧或单侧消融相比不增加发病率。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议2015-2019年数据,纳入5029例接受主干静脉腔内消融的慢性静脉功能不全患者,其中3782例(75.2%)为单侧手术。
  • 中位随访227天(四分位距55-788天)。

临床怎么用

  • 对于适合的双侧慢性静脉功能不全患者,可考虑同期双侧主干静脉腔内消融,而不增加并发症风险。
  • 单侧与双侧手术在VCSS改善上效果相当,选择术式时可结合患者偏好和临床情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Venous insufficiency is commonly bilateral, and patients often prefer single-episode care compared with staged procedures. Few studies have investigated clinical outcomes after unilateral vs bilateral venous ablation procedures or between staged and concurrent bilateral procedures. Here, we report data from the Vascular Quality Initiative regarding truncal venous ablation for chronic venous insufficiency. METHODS: Using data from the Vascular Quality Initiative, we investigated immediate postoperative as well as long-term clinical and patient-reported outcomes of patients undergoing unilateral vs bilateral truncal endovenous ablation from 2015 to 2019. We further investigated outcomes between staged bilateral and concurrent bilateral ablations. Preprocedural and postprocedural comparisons were performed using t-test, χ2 test, or their nonparametric counterpart when appropriate. Multivariable ordinal logistic regression was performed on ordinal outcome variables. RESULTS: A total of 5029 patients were included, of whom 3782 (75.2%) underwent unilateral procedures. Median follow-up was 227 days (interquartile range [IQR], 55-788 days). Unilateral patients were less likely to be female (67.0% vs 70.3%; P = .031) and white (86.3% vs 91.2%; P < .001) and had lower body mass index (30.3 ± 7.3 kg/m2 vs 31.8 ± 7.6 kg/m2; P < .001) compared with patients undergoing bilateral procedures. In addition, unilateral patients had fewer prior varicose vein treatments (23.0% vs 15.7%; P < .001) and had higher median preprocedural Venous Clinical Severity Score (VCSS; 8 [IQR, 6-10] vs 7 [IQR, 5.5-9]; P < .001). No difference was seen in complications (6.9% vs 8.2%; P = .292), and systemic complications were rare in both groups. No difference was seen in VCSS improvement after treatment (median, 3 [IQR, 1-6] for unilateral; median, 3 [IQR 1-5] for bilateral; P = .055). In comparing staged with concurrent bilateral procedures, there was no difference in overall complications (7.5% vs 12.2%; P = .144). Staged bilateral patients were older (56.9 ± 13.3 years vs 54.2 ± 12.9 years; P = .002), less likely to have had prior varicose vein treatment (14.3% vs 19.8%; P = .020), and more likely to be therapeutically anticoagulated (10.8% vs 6.5%; P = .028) compared with concurrent bilateral patients. Staged patients also have higher preprocedural VCSS compared with concurrent patients (median, 8 [IQR, 6-10] vs 7 [IQR, 5.5-9]; P < .001). In multivariable analysis, there was no difference in the likelihood of VCSS improvement for concurrent compared with staged procedures (odds ratio, 0.70; 95% confidence interval, 0.40-1.24; P = .226). CONCLUSIONS: Concurrent bilateral truncal endovenous ablation can be performed safely without increased morbidity compared with staged bilateral or unilateral ablations.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Brown CS, Osborne NH, Kim GY, et al. Comparison of unilateral vs bilateral and staged bilateral vs concurrent bilateral truncal endovenous ablation in the Vascular Quality Initiative. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32470615. doi:10.1016/j.jvsv.2020.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。